Literature DB >> 15901156

Synthetic studies on the bryostatins: preparation of a truncated BC-ring intermediate by pyran annulation.

Gary E Keck1, Anh P Truong.   

Abstract

[reaction: see text]. A synthesis of a potential BC-ring subunit (C9-C27) for bryostatin 1, a remarkably potent anticancer agent, has been developed in 16 steps and 18% overall yield. The key features of this route include a BITIP-catalyzed asymmetric allylation reaction, chelation-controlled allylations, a hydroformylation reaction, and a pyran annulation reaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15901156      PMCID: PMC1480406          DOI: 10.1021/ol050511w

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  11 in total

1.  Total Synthesis of Bryostatin 3 This work was supported by the Ministry of Education, Science, Sports, and Culture (Japan). K.O. is grateful to JSPS for a predoctoral fellowship. The authors thank Dr. G. N. Chmurny (NIH) for providing them with (1)H and (13)C NMR spectra of bryostatin 3 and for helpful discussions.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-07-03       Impact factor: 15.336

2.  New, abridged pathway to Masamune's "southern hemisphere" intermediate for the total synthesis of bryostatin 7.

Authors:  Karl J Hale; Mark Frigerio; Soraya Manaviazar
Journal:  Org Lett       Date:  2003-02-20       Impact factor: 6.005

3.  The practical synthesis of a novel and highly potent analogue of bryostatin.

Authors:  Paul A Wender; Jeremy L Baryza; Chad E Bennett; F Christopher Bi; Stacey E Brenner; Michael O Clarke; Joshua C Horan; Cindy Kan; Emmanuel Lacôte; Blaise Lippa; Peter G Nell; Tim M Turner
Journal:  J Am Chem Soc       Date:  2002-11-20       Impact factor: 15.419

Review 4.  The chemistry and biology of the bryostatin antitumour macrolides.

Authors:  Karl J Hale; Marc G Hummersone; Soraya Manaviazar; Mark Frigerio
Journal:  Nat Prod Rep       Date:  2002-08       Impact factor: 13.423

5.  Synthesis of the bryostatin 1 northern hemisphere (C1-C16) via desymmetrization by ketalization/ring-closing metathesis.

Authors:  Eric A Voight; Hassan Seradj; Paul A Roethle; Steven D Burke
Journal:  Org Lett       Date:  2004-10-28       Impact factor: 6.005

6.  Synthetic studies on the bryostatins: synthetic routes to analogues containing the tricyclic macrolactone core.

Authors:  Gary E Keck; Anh P Truong
Journal:  Org Lett       Date:  2005-05-26       Impact factor: 6.005

7.  Enantio- and diastereoselective additions to aldehydes using the bifunctional reagent 2-(chloromethyl)-3-(tributylstannyl)propene: application to a synthesis of the C16-C27 segment of bryostatin 1.

Authors:  Gary E Keck; Tao Yu; Mark D McLaws
Journal:  J Org Chem       Date:  2005-04-01       Impact factor: 4.354

Review 8.  Chemistry and clinical biology of the bryostatins.

Authors:  R Mutter; M Wills
Journal:  Bioorg Med Chem       Date:  2000-08       Impact factor: 3.641

9.  Pyran annulation: asymmetric synthesis of 2,6-disubstituted-4-methylene tetrahydropyrans.

Authors:  Gary E Keck; Jonathan A Covel; Tobias Schiff; Tao Yu
Journal:  Org Lett       Date:  2002-04-04       Impact factor: 6.005

10.  Concise formal synthesis of the bryostatin southern hemisphere (C17-C27).

Authors:  Eric A Voight; Paul A Roethle; Steven D Burke
Journal:  J Org Chem       Date:  2004-06-25       Impact factor: 4.354

View more
  18 in total

1.  Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis.

Authors:  Paul A Wender; Brian A Loy; Adam J Schrier
Journal:  Isr J Chem       Date:  2011-03-24       Impact factor: 3.333

2.  Total synthesis of bryostatin 1.

Authors:  Gary E Keck; Yam B Poudel; Thomas J Cummins; Arnab Rudra; Jonathan A Covel
Journal:  J Am Chem Soc       Date:  2010-12-22       Impact factor: 15.419

3.  Synthetic studies toward the bryostatins: a substrate-controlled approach to the A-ring.

Authors:  Gary E Keck; Dennie S Welch; Paige K Vivian
Journal:  Org Lett       Date:  2006-08-17       Impact factor: 6.005

4.  A new construction of 2-alkoxypyrans by an acylation-reductive cyclization sequence.

Authors:  Lars V Heumann; Gary E Keck
Journal:  Org Lett       Date:  2007-04-12       Impact factor: 6.005

5.  Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters.

Authors:  Gary E Keck; Yam B Poudel; Dennie S Welch; Matthew B Kraft; Anh P Truong; Jeffrey C Stephens; Noemi Kedei; Nancy E Lewin; Peter M Blumberg
Journal:  Org Lett       Date:  2009-02-05       Impact factor: 6.005

6.  Convergent assembly of highly potent analogues of bryostatin 1 via pyran annulation: bryostatin look-alikes that mimic phorbol ester function.

Authors:  Gary E Keck; Matthew B Kraft; Anh P Truong; Wei Li; Carina C Sanchez; Noemi Kedei; Nancy E Lewin; Peter M Blumberg
Journal:  J Am Chem Soc       Date:  2008-05-02       Impact factor: 15.419

7.  Synthesis and Biological Evaluation of Fluorescent Bryostatin Analogues.

Authors:  Thomas J Cummins; Noemi Kedei; Agnes Czikora; Nancy E Lewin; Sharon Kirk; Mark E Petersen; Kevin M McGowan; Jin-Qiu Chen; Xiaoling Luo; Randall C Johnson; Sarangan Ravichandran; Peter M Blumberg; Gary E Keck
Journal:  Chembiochem       Date:  2018-03-25       Impact factor: 3.164

8.  Deletion of the C26 Methyl Substituent from the Bryostatin Analogue Merle 23 Has Negligible Impact on Its Biological Profile and Potency.

Authors:  Xiguang Zhao; Noemi Kedei; Alexandra Michalowski; Nancy E Lewin; Gary E Keck; Peter M Blumberg
Journal:  Chembiochem       Date:  2018-04-27       Impact factor: 3.164

9.  Synthetic studies on the bryostatins: synthetic routes to analogues containing the tricyclic macrolactone core.

Authors:  Gary E Keck; Anh P Truong
Journal:  Org Lett       Date:  2005-05-26       Impact factor: 6.005

10.  Synthetic Studies Toward Bryostatin 1: Preparation of a C(1)-C(16) Fragment by Pyran Annulation.

Authors:  Gary E Keck; Dennie S Welch; Yam B Poudel
Journal:  Tetrahedron Lett       Date:  2006-11-20       Impact factor: 2.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.